|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $317,370 at March 31, 2025 and $319,939 at December 31, 2024) | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $303,767 at June 30, 2026 and $299,162 at December 31, 2025) | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") stock | ||||||||||||||||||||
| Federal Reserve Bank ("FRB") stock | ||||||||||||||||||||
| Mortgage loans held-for-sale, at fair value | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $16,720 at March 31, 2025 and $16,850 at December 31, 2024 | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $17,640 at June 30, 2026 and $17,370 at December 31, 2025 | ||||||||||||||||||||
| Accrued interest and dividends receivable | ||||||||||||||||||||
| Mortgage servicing rights, net | ||||||||||||||||||||
| Assets held-for-sale, at cost | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Cash surrender value of life insurance, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| FHLB advances and other borrowings | ||||||||||||||||||||
| Other long-term debt: | ||||||||||||||||||||
| Principal amount | ||||||||||||||||||||
| Unamortized debt issuance costs | ||||||||||||||||||||
| Total other long-term debt, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY: | ||||||||||||||||||||
| Preferred stock (par value $0.01 per share; 1,000,000 shares authorized; no shares issued or outstanding) | ||||||||||||||||||||
| Common stock (par value $0.01 per share; 20,000,000 shares authorized; 8,507,429 shares issued at June 30, 2026 and December 31, 2025; 7,965,431 shares outstanding at June 30, 2026 and 7,957,769 shares outstanding at December 31, 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Unallocated common stock held by Employee Stock Ownership Plan ("ESOP") | ||||||||||||||||||||
| Treasury stock, at cost (541,998 shares at June 30, 2026 and 549,660 shares at December 31, 2025) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
